SCHEMBL10068289

SCHEMBL10068289

CCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 15/20 0.83
CNR1 P21554 13/20 0.83
TRPM8 Q7Z2W7 2/20 0.83
GPR55 Q9Y2T6 2/20 0.83
TRPA1 O75762 1/20 0.83
HTR1A P08908 1/20 0.83
TRPV1 Q8NER1 1/20 0.83
TRPV3 Q8NET8 1/20 0.83
TRPV6 Q9H1D0 1/20 0.83
TRPV4 Q9HBA0 1/20 0.83
TRPV5 Q9NQA5 1/20 0.83
TRPV2 Q9Y5S1 1/20 0.83
ABHD12 Q8N2K0 3/20 0.78
ABHD6 Q9BV23 3/20 0.78
FAAH O00519 2/20 0.78
NR1I2 O75469 1/20 0.78
LDHA P00338 1/20 0.78
GLRA1 P23415 1/20 0.78
GPR183 P32249 1/20 0.78
DRD3 P35462 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14112549 1.00 CNR2 (0.83) CNR2CNR1TRPM8GPR55TRPA1
SCHEMBL22705427 1.00 CNR2 (0.83) CNR2CNR1TRPM8GPR55TRPA1
SCHEMBL29422028 1.00 CNR2 (0.83) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL31544930 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL18371743 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL6856739 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL31300003 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL21363566 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL245827 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1
Tetrahydrocannabivarin SCHEMBL30017852 0.91 CNR2 (1.00) CNR2CNR1TRPM8GPR55TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102655-A1 CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2023-06-15 WO disclosed
US-9155797-B2 Oligomer-cannabinoid conjugates NEKTAR THERAPEUTICS (US) 2015-10-13 US disclosed
US-20140329895-A1 OLIGOMER-CANNABINOID CONJUGATES NEKTAR THERAPEUTICS 2014-11-06 US disclosed
US-8829043-B2 Oligome-cannabinoid conjugates NEKTAR THERAPEUTICS (US) 2014-09-09 US disclosed
US-20120022063-A1 Oligomer-Cannabinoid Conjugates NEKTAR THERAPEUTICS (US) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329895-A1 OLIGOMER-CANNABINOID CONJUGATES CNR2, CNR1, OPRL1 CNR2 1/4885CNR1 2/4885TRPM8 1305/4885
US-20120022063-A1 Oligomer-Cannabinoid Conjugates CNR2, CNR1, OPRL1 CNR2 1/4885CNR1 2/4885TRPM8 1305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.